Mueller Lab at ASGCT
Tuesday, April 26, 2016
|
The Mueller Lab will be presenting its research at ASGCT 2016, May 4-7 in Washington, DC.
Wednesday, May 4
AAV Vectors I: Gwladys Gernoux will be presenting "Vector Biodistribution After Recombinant AAVrh10 Intrathecal Delivery in Non-Human Primates"
Diabetes, Metabolic and Genetic Diseases I: Florie Borel will be presenting "Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD"
Thursday, May 5
Scientific Symposium 202, Chris Mueller will be presenting: "Genome Editing the First Animal Model of Emphysema Due to Alpha-1 Antitrypsin Deficiency"
Friday, May 6
Immunological Aspects of Gene Therapy II: AAV Vectors, Gwladys Gernoux will be presenting: "Detection and Isolation of Immune Cells After Intramuscular AAV Injection in Mouse and Human"
Saturday, May 7
Oligonucleotide Therapeutics II, Gabriela Toro will be presenting: "Engineered MicroRNA Silences C9ORF72 Variants in BAC Transgenic Mouse"
